Seda Atay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Seda Atay has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Nejat Ünlükal
School of Medicine Department of Histology and Embryology Selcuk University Konya Turkey
3 shared publications - Duygu İlKe Yildirim
Selçuk Üniversitesi Tıp Fakültesi, Aile Hekimliği Anabilim Dalı
2 shared publications - Fikret Akyürek
Department of Medical Biochemistry, Faculty of Medicine, University of Selçuk, Konya, Türkiye
2 shared publications - Halil Güven
Department of Medical Biochemistry, Faculty of Medicine, University of Selçuk, Konya, Türkiye
2 shared publications - Seyit Muhammed Soycan
Selçuk Üniversitesi Tıp Fakültesi Hastanesi, Konya, Turkey
2 shared publications - Abdullah Şentürk
Department of Histology and Embryology, Medicine Faculty, Selcuk University, Konya 42700, Turkey
1 shared publication
Latest Publications
- 17 July 2026
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 127 (8) , 3503-3513
Evaluation of the Relationships of Fisetin and Atorvastatin with Adipokine, Hepatokine, Myokine Profiles and Metabolic Parameters in Rats Fed with High-Fat Diet
- 17 July 2026
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 127 (8) , 3503-3513
Evaluation of the Relationships of Fisetin and Atorvastatin with Adipokine, Hepatokine, Myokine Profiles and Metabolic Parameters in Rats Fed with High-Fat Diet
- Open Access
The Expression of Kisspeptin Receptor, Catsper 3 and Acrosome Integrity in Oligozoospermic and Normozoospermic Individuals
Background: Male infertility remains a significant clinical challenge. The KISS1R-CATSPER3 signaling axis and acrosomal integrity are vital for fertilization, yet their regional expression patterns in subfertile men are not fully characterized. Objectives: This study investigated regional expression patterns of KISS1R and CATSPER3 and evaluated acrosomal integrity in oligozoospermic and normozoospermic individuals, accounting for demographic confounders. Methods: A total of 52 participants were selected from 568 candidates and divided into normozoospermic (n = 26) and oligozoospermic (n = 26) groups. Analysis included qPCR and immunofluorescence for KISS1R and CATSPER3. Regional expression was independently scored by blinded researchers. Statistical models were adjusted for age and body mass index (BMI). Results: Acrosomal integrity was significantly lower in the oligozoospermic group (p < 0.001). After adjusting for age and BMI, overall protein expression of CATSPER3 and KISS1R remained significantly lower in oligozoospermic men (p < 0.05). Regional analysis showed that CATSPER3 head staining differences disappeared after adjustment, whereas lower tail expression persisted. Higher KISS1R head expression in oligozoospermic men remained significant. qPCR showed no differences in KISS1R or CATSPER3 mRNA levels (p > 0.05), indicating post-translational regulation. Conclusions: KISS1R-CATSPER3 axis downregulation is a hallmark of oligozoospermia that persists independently of age and BMI. Regional protein instability, despite stable mRNA levels, suggests that post-translational regulation is critical for fertility. These markers may serve as potential diagnostic or therapeutic indicators for male infertility.
Open AccessThe Expression of Kisspeptin Receptor, Catsper 3 and Acrosome Integrity in Oligozoospermic and Normozoospermic Individuals
Background: Male infertility remains a significant clinical challenge. The KISS1R-CATSPER3 signaling axis and acrosomal integrity are vital for fertilization, yet their regional expression patterns in subfertile men are not fully characterized. Objectives: This study investigated regional expression patterns of KISS1R and CATSPER3 and evaluated acrosomal integrity in oligozoospermic and normozoospermic individuals, accounting for demographic confounders. Methods: A total of 52 participants were selected from 568 candidates and divided into normozoospermic (n = 26) and oligozoospermic (n = 26) groups. Analysis included qPCR and immunofluorescence for KISS1R and CATSPER3. Regional expression was independently scored by blinded researchers. Statistical models were adjusted for age and body mass index (BMI). Results: Acrosomal integrity was significantly lower in the oligozoospermic group (p < 0.001). After adjusting for age and BMI, overall protein expression of CATSPER3 and KISS1R remained significantly lower in oligozoospermic men (p < 0.05). Regional analysis showed that CATSPER3 head staining differences disappeared after adjustment, whereas lower tail expression persisted. Higher KISS1R head expression in oligozoospermic men remained significant. qPCR showed no differences in KISS1R or CATSPER3 mRNA levels (p > 0.05), indicating post-translational regulation. Conclusions: KISS1R-CATSPER3 axis downregulation is a hallmark of oligozoospermia that persists independently of age and BMI. Regional protein instability, despite stable mRNA levels, suggests that post-translational regulation is critical for fertility. These markers may serve as potential diagnostic or therapeutic indicators for male infertility.
- Open Access
- 12 November 2025
- Published by Springer Nature in Research Square
Evaluation of the Relationships of Fisetin and Atorvastatin with Adipokine, Hepatokine, Myokine Profiles and Metabolic Parameters in Rats Fed with High-Fat Diet
Objective The aim of this study is to evaluate the effects of fisetin and atorvastatin administration on metabolic parameters and adipokine, hepatokine, and myokine profiles in rats fed a high-fat diet (HFD). Additionally, the effects of these agents on liver and skeletal muscle histology were investigated. Methods In the study, male Sprague-Dawley rats were randomly divided into five groups: K(Control), Y(HFD), YF(HFD + Fisetin), YA(HFD + Atorvastatin) and YAF(HFD + Atorvastatin + Fisetin). The Y groups were fed a high-fat diet for 8 weeks. The intervention groups were administered fisetin (50 mg/kg/day) and atorvastatin (10 mg/kg/day) orally via gavage in addition to the high-fat diet for 8 weeks. At the end of the study, blood biochemistry, asprosin, fetuin-A, GDF-15, Metrnl, and histological changes in liver and gastrocnemius muscle tissue were examined. Results Histopathological examinations revealed significant structural damage in liver and muscle tissues in groups treated with HFD, while these damages were significantly reduced in the combined treatment group. However, limited effects were observed on LDL-C and TG levels in the biochemical data; an increase in total cholesterol, a decrease in glucose levels, and improvements in creatinine and urea levels were detected. No significant differences were observed in adipokine, hepatokine, and myokine levels between the groups. Conclusion The combination of fisetin and atorvastatin significantly reduced HFD-induced liver and muscle tissue damage at the histological level. In terms of biochemical parameters, the combination therapy may be protective at the tissue level, but its effects on metabolic regulation may be limited depending on the dose and duration. Therefore, pharmacodynamic interactions and optimal dosage should be investigated in more detail.
- 12 November 2025
- Published by Springer Nature in Research Square
Open AccessEvaluation of the Relationships of Fisetin and Atorvastatin with Adipokine, Hepatokine, Myokine Profiles and Metabolic Parameters in Rats Fed with High-Fat Diet
Objective The aim of this study is to evaluate the effects of fisetin and atorvastatin administration on metabolic parameters and adipokine, hepatokine, and myokine profiles in rats fed a high-fat diet (HFD). Additionally, the effects of these agents on liver and skeletal muscle histology were investigated. Methods In the study, male Sprague-Dawley rats were randomly divided into five groups: K(Control), Y(HFD), YF(HFD + Fisetin), YA(HFD + Atorvastatin) and YAF(HFD + Atorvastatin + Fisetin). The Y groups were fed a high-fat diet for 8 weeks. The intervention groups were administered fisetin (50 mg/kg/day) and atorvastatin (10 mg/kg/day) orally via gavage in addition to the high-fat diet for 8 weeks. At the end of the study, blood biochemistry, asprosin, fetuin-A, GDF-15, Metrnl, and histological changes in liver and gastrocnemius muscle tissue were examined. Results Histopathological examinations revealed significant structural damage in liver and muscle tissues in groups treated with HFD, while these damages were significantly reduced in the combined treatment group. However, limited effects were observed on LDL-C and TG levels in the biochemical data; an increase in total cholesterol, a decrease in glucose levels, and improvements in creatinine and urea levels were detected. No significant differences were observed in adipokine, hepatokine, and myokine levels between the groups. Conclusion The combination of fisetin and atorvastatin significantly reduced HFD-induced liver and muscle tissue damage at the histological level. In terms of biochemical parameters, the combination therapy may be protective at the tissue level, but its effects on metabolic regulation may be limited depending on the dose and duration. Therefore, pharmacodynamic interactions and optimal dosage should be investigated in more detail.